Taxus Cardium Pharmaceuticals Probability of Future Pink Sheet Price Finishing Over 1.0E-4
| CRXMDelisted Stock | USD 0.0001 0.00 0.00% |
Taxus |
Taxus Cardium Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Taxus Cardium for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Taxus Cardium Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Taxus Cardium Pharma is not yet fully synchronised with the market data | |
| Taxus Cardium Pharma has some characteristics of a very speculative penny stock | |
| Taxus Cardium Pharma has a very high chance of going through financial distress in the upcoming years | |
| Taxus Cardium Pharmaceuticals currently holds 1.26 M in liabilities. Taxus Cardium Pharma has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Taxus Cardium until it has trouble settling it off, either with new capital or with free cash flow. So, Taxus Cardium's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Taxus Cardium Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Taxus to invest in growth at high rates of return. When we think about Taxus Cardium's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (517.9 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Taxus Cardium Pharmaceuticals currently holds about 386.03 K in cash with (1.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Taxus Cardium Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Taxus Pink Sheet often depends not only on the future outlook of the current and potential Taxus Cardium's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Taxus Cardium's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 14.5 M | |
| Cash And Short Term Investments | 386 K |
Taxus Cardium Technical Analysis
Taxus Cardium's future price can be derived by breaking down and analyzing its technical indicators over time. Taxus Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Taxus Cardium Pharmaceuticals. In general, you should focus on analyzing Taxus Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Taxus Cardium Predictive Forecast Models
Taxus Cardium's time-series forecasting models is one of many Taxus Cardium's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Taxus Cardium's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Taxus Cardium Pharma
Checking the ongoing alerts about Taxus Cardium for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Taxus Cardium Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Taxus Cardium Pharma is not yet fully synchronised with the market data | |
| Taxus Cardium Pharma has some characteristics of a very speculative penny stock | |
| Taxus Cardium Pharma has a very high chance of going through financial distress in the upcoming years | |
| Taxus Cardium Pharmaceuticals currently holds 1.26 M in liabilities. Taxus Cardium Pharma has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Taxus Cardium until it has trouble settling it off, either with new capital or with free cash flow. So, Taxus Cardium's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Taxus Cardium Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Taxus to invest in growth at high rates of return. When we think about Taxus Cardium's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (517.9 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Taxus Cardium Pharmaceuticals currently holds about 386.03 K in cash with (1.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Taxus Pink Sheet
If you are still planning to invest in Taxus Cardium Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taxus Cardium's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world |